CD8A and neuroblastoma: In another syngeneic model, the combination of an anti-CD4 mAb with an IL-21-secerting neuroblastoma (NB) cell vaccine [115] or rIL-21 [116] induced potent CD8+ T cell responses and cooperatively cured most mice bearing systemic NB.